Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
251
-
Total 13F shares, excl. options
-
37.6M
-
Shares change
-
+206K
-
Total reported value, excl. options
-
$3.55B
-
Value change
-
+$20.3M
-
Number of buys
-
129
-
Number of sells
-
-113
-
Price
-
$94.52
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q1 2016
280 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q1 2016.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 251 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.6M shares
of 152M outstanding shares and own 24.66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.68M shares), BROWN CAPITAL MANAGEMENT LLC (2.49M shares), Select Equity Group, L.P. (2.38M shares), BlackRock Fund Advisors (1.77M shares), Jackson Square Partners, LLC (1.73M shares), BAMCO INC /NY/ (1.66M shares), Neuberger Berman Group LLC (1.47M shares), JANUS CAPITAL MANAGEMENT LLC (1.37M shares), Mairs & Power INC (1.31M shares), and ATLANTA CAPITAL MANAGEMENT CO L L C (1.25M shares).
This table shows the top 251 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.